HLB Cell is a regenerative medicine biotechnology company
dedicated to deeply understanding the fundamental unit of life — the cell —
and leveraging this knowledge to design a healthier future for humanity.
We have established the proprietary Hutrigel® Platform technology
based on human normal cell-derived extracellular matrix (ECM),
enabling the development of medical biomaterials and mesotherapy solutions
that go beyond symptomatic treatment to achieve substantial regeneration of damaged biological tissues.
In addition, through the in-house development and manufacturing of BleeFix®,
a bioresorbable surgical hemostatic agent with enhanced biodegradability,
HLB Cell is strengthening its distinctive competitiveness
in the high-value medical device sector that demands advanced technological expertise.
HLB Cell’s innovative biomaterial technologies are overcoming
the limitations of conventional tissue engineering,
contributing to faster patient recovery and improved clinical efficiency.
We remain committed to developing next-generation biomedical materials and medical devices
so that people around the world may enjoy a better quality of life — Human Life Better.